Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
338.36
+0.87 (+0.26%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
61
62
Next >
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
↗
April 11, 2025
Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
Via
Benzinga
Topics
Government
World Trade
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
↗
April 10, 2025
Here's why the 90-day tariffs delay doesn't help pharmaceutical companies.
Via
Investor's Business Daily
Topics
Government
Stocks
World Trade
Rule Breaker Investing: Essays From Yesterday, Vol. 7
↗
April 10, 2025
Via
The Motley Fool
P/E Ratio Insights for Amgen
↗
April 07, 2025
Via
Benzinga
P/E Ratio Insights for Amgen
↗
April 02, 2025
Via
Benzinga
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
↗
April 09, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.
Via
Chartmill
Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
↗
April 09, 2025
Big pharmaceutical names plowed lower Wednesday after Trump on Tuesday said that tariffs would take aim at drug imports.
Via
Investor's Business Daily
Topics
Government
Stocks
World Trade
Trump Hints At 'Major Tariff' On Imported Pharmaceuticals: Pfizer, Eli Lilly, Amgen And Other Stocks Tumble In Wednesday Pre-Market
↗
April 09, 2025
President Donald Trump has declared that his administration is on the brink of imposing a significant tariff on pharmaceuticals imported from foreign countries.
Via
Benzinga
Topics
Government
World Trade
3 Dividend Stocks to Buy and Hold for the Next Decade
↗
April 06, 2025
Via
The Motley Fool
Topics
Economy
Intellectual Property
2 Dividend Stocks to Buy Hand Over Fist in April
↗
April 05, 2025
Via
The Motley Fool
Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
↗
April 04, 2025
Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.
Via
Benzinga
Topics
Government
World Trade
Nasdaq 100 Enters Bear Market, Dow In Correction Territory, Traders Await Fed Chair Powell's Remarks
↗
April 04, 2025
Dip-buying absent in early NY trading, Wall Street deep in red as trade war fears escalate despite strong jobs report. Investors on edge for hints from Fed Chair Powell.
Via
Benzinga
Topics
Economy
Stocks
World Trade
FDA Approves Amgen's Uplizna As First Drug For Chronic Immune-Mediated Fibroinflammatory Disorder
↗
April 04, 2025
The FDA approved Amgen's Uplizna as the first treatment for IgG4-RD. The decision is backed by the MITIGATE trial, showing reduced flares and sustained efficacy.
Via
Benzinga
Amgen Stock Edges Higher After Uplizna Becomes First FDA-Approved Treatment For Immune-Mediated Disorder – Retail Gets More Bullish
↗
April 04, 2025
Uplizna is now the first FDA-approved treatment for Immunoglobulin G4-related disease, affecting an estimated 20,000 people in the United States
Via
Stocktwits
Topics
Government
World Trade
Amgen, Sabra Health Care And A Financial Stock On CNBC's 'Final Trades'
↗
April 04, 2025
Via
Benzinga
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday
↗
April 03, 2025
Via
The Motley Fool
Topics
Economy
Government
World Trade
Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks
April 03, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with Amgen...
Via
StockStory
Topics
Artificial Intelligence
Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now
↗
April 03, 2025
Via
The Motley Fool
Topics
Economy
Stocks
World Trade
Amgen Options Trading: A Deep Dive into Market Sentiment
↗
April 01, 2025
Via
Benzinga
Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?
↗
March 31, 2025
The company unveiled promising results for its experimental cholesterol treatment, a daily pill that blocks PCSK9.
Via
Investor's Business Daily
2 Surefire Dividend Stocks That Could Pay You for Life
↗
March 28, 2025
Via
The Motley Fool
2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down
March 28, 2025
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...
Via
StockStory
Which Dow Jones Stock Is Cheaper, Amgen or Merck?
↗
March 28, 2025
Via
The Motley Fool
Topics
Intellectual Property
Stocks
Is the Market Bullish or Bearish on Amgen?
↗
March 26, 2025
Via
Benzinga
Why Pharma and Biotech Stocks Got Thrashed on Tuesday
↗
March 25, 2025
Via
The Motley Fool
Amgen Options Trading: A Deep Dive into Market Sentiment
↗
March 25, 2025
Via
Benzinga
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
↗
March 22, 2025
Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
March 21, 2025
Via
Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
↗
March 21, 2025
UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highlights declining UK R&D investment and falling global competitiveness.
Via
Benzinga
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)
March 21, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including BioMarin Pharmaceutical (NASDAQ:BMRN) and its...
Via
StockStory
Topics
Artificial Intelligence
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
61
62
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
